Literature DB >> 33847297

Coronavirus Disease 2019 in Pregnancy and Outcomes Among Pregnant Women and Neonates: A Literature Review.

Elyse G Mark1, Samuel McAleese1, W Christopher Golden1, Maureen M Gilmore1, Anna Sick-Samuels2, Melanie S Curless3, Lawrence M Nogee1, Aaron M Milstone2, Julia Johnson1.   

Abstract

Limited data are available about the outcomes of coronavirus disease 2019 (COVID-19) during pregnancy and risk of vertical transmission in exposed neonates. We reviewed studies published February 1, 2020, through August 15, 2020, on outcomes in pregnant women with COVID-19 and neonates with perinatal exposure. Among pregnant women with COVID-19, 181 (11%) required intensive care unit admission and 123 (8%) required mechanical ventilation. There were 22 maternal deaths. Most infections occurred in the third trimester. Among women who delivered, 28% had a preterm birth, and 57% had a Caesarean section. Sixty-one (4%) of 1222 neonates with reported testing had at least 1 positive severe acute respiratory syndrome coronavirus 2 polymerase chain reaction test. The most common symptom among neonates was respiratory distress (n = 126; 21%). There were 14 neonatal deaths, one of which occurred in a neonate with positive testing. Further study of COVID-19 in pregnant women and neonates, including standardized reporting of outcomes, testing and treatment protocols, is essential to optimize maternal and neonatal care.
Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved.

Entities:  

Mesh:

Year:  2021        PMID: 33847297      PMCID: PMC8048372          DOI: 10.1097/INF.0000000000003102

Source DB:  PubMed          Journal:  Pediatr Infect Dis J        ISSN: 0891-3668            Impact factor:   2.129


  57 in total

1.  Screening for COVID-19 at childbirth: is it effective?

Authors:  D Ceulemans; I Thijs; A Schreurs; J Vercammen; L Lannoo; J Deprest; J Richter; L De Catte; R Devlieger
Journal:  Ultrasound Obstet Gynecol       Date:  2020-07       Impact factor: 7.299

2.  Can SARS-CoV-2 Infection Be Acquired In Utero?: More Definitive Evidence Is Needed.

Authors:  David W Kimberlin; Sergio Stagno
Journal:  JAMA       Date:  2020-05-12       Impact factor: 56.272

Review 3.  Global epidemiology of use of and disparities in caesarean sections.

Authors:  Ties Boerma; Carine Ronsmans; Dessalegn Y Melesse; Aluisio J D Barros; Fernando C Barros; Liang Juan; Ann-Beth Moller; Lale Say; Ahmad Reza Hosseinpoor; Mu Yi; Dácio de Lyra Rabello Neto; Marleen Temmerman
Journal:  Lancet       Date:  2018-10-13       Impact factor: 79.321

4.  COVID-19 in a 26-week preterm neonate.

Authors:  Fiammetta Piersigilli; Katherine Carkeek; Catheline Hocq; Bénédicte van Grambezen; Corinne Hubinont; Olga Chatzis; Dimitri Van der Linden; Olivier Danhaive
Journal:  Lancet Child Adolesc Health       Date:  2020-05-07

5.  Possible formation of pulmonary microthrombi in the early puerperium of pregnant women critically ill with COVID-19: Two case reports.

Authors:  Celso T Tutiya; Monica M Siaulys; Mario M Kondo; Lisia Miglioli-Galvão; Elaine C A Galvão; Cilene C Pinheiro; Maria Regina Torloni; Filomena B de Mello
Journal:  Case Rep Womens Health       Date:  2020-06-27

6.  Neonatal management and outcomes during the COVID-19 pandemic: an observation cohort study.

Authors:  Christine M Salvatore; Jin-Young Han; Karen P Acker; Priyanka Tiwari; Jenny Jin; Michael Brandler; Carla Cangemi; Laurie Gordon; Aimee Parow; Jennifer DiPace; Patricia DeLaMora
Journal:  Lancet Child Adolesc Health       Date:  2020-07-23

7.  Low Prevalence of Severe Acute Respiratory Syndrome Coronavirus 2 Among Pregnant and Postpartum Patients With Universal Screening in Seattle, Washington.

Authors:  Sylvia M LaCourse; Alisa Kachikis; Michela Blain; LaVone E Simmons; James A Mays; Amber D Pattison; Carol C Salerno; Stephen A McCartney; Nicole M Kretzer; Rebecca Resnick; Rosemary L Shay; Leah M Savitsky; Anna C Curtin; Emily M Huebner; Kimberly K Ma; Shani Delaney; Carlos Delgado; Adrienne Schippers; Jeff Munson; Paul S Pottinger; Seth Cohen; Santiago Neme; Lori Bourassa; Andrew Bryan; Alex Greninger; Keith R Jerome; Alison C Roxby; Erica Lokken; Edith Cheng; Kristina M Adams Waldorf; Jane Hitti
Journal:  Clin Infect Dis       Date:  2021-03-01       Impact factor: 9.079

8.  Severe acute respiratory syndrome coronavirus 2 in pregnancy: symptomatic pregnant women are only the tip of the iceberg.

Authors:  Asma Khalil; Robert Hill; Shamez Ladhani; Katherine Pattisson; Pat O'Brien
Journal:  Am J Obstet Gynecol       Date:  2020-05-07       Impact factor: 8.661

9.  A case-controlled study comparing clinical course and outcomes of pregnant and non-pregnant women with severe acute respiratory syndrome.

Authors:  Chui Miu Lam; Shell Fean Wong; Tse Ngong Leung; Kam Ming Chow; Wai Cho Yu; Tin Yau Wong; Sik To Lai; Lau Cheung Ho
Journal:  BJOG       Date:  2004-08       Impact factor: 6.531

10.  Maternal death due to COVID-19.

Authors:  Sedigheh Hantoushzadeh; Alireza A Shamshirsaz; Ashraf Aleyasin; Maxim D Seferovic; Soudabeh Kazemi Aski; Sara E Arian; Parichehr Pooransari; Fahimeh Ghotbizadeh; Soroush Aalipour; Zahra Soleimani; Mahsa Naemi; Behnaz Molaei; Roghaye Ahangari; Mohammadreza Salehi; Atousa Dabiri Oskoei; Parisa Pirozan; Roya Faraji Darkhaneh; Mahboobeh Gharib Laki; Ali Karimi Farani; Shahla Atrak; Mir Mohammad Miri; Mehran Kouchek; Seyedpouzhia Shojaei; Fahimeh Hadavand; Fatemeh Keikha; Maryam Sadat Hosseini; Sedigheh Borna; Shideh Ariana; Mamak Shariat; Alireza Fatemi; Behnaz Nouri; Seyed Mojtaba Nekooghadam; Kjersti Aagaard
Journal:  Am J Obstet Gynecol       Date:  2020-04-28       Impact factor: 10.693

View more
  2 in total

1.  COVID-19 FAQs in Pediatric Cardiac Surgery: 2022 Perspective and Updates.

Authors:  Emily R Levy; Joseph A Dearani; Jennifer Blumenthal; Jonathan N Johnson; David M Overman; Elizabeth H Stephens; Kathleen Chiotos
Journal:  World J Pediatr Congenit Heart Surg       Date:  2022-03-28

Review 2.  Neurological effects of COVID-19 in infants and children.

Authors:  Carl E Stafstrom
Journal:  Dev Med Child Neurol       Date:  2022-03-03       Impact factor: 4.864

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.